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Abstract
Background: Coronary artery bypass graft (CABG) surgery is performed because of anticipated
survival benefit, improvement in quality of life, or both. We performed this study to explore
variations in clinical indications for CABG surgery among California hospitals and surgeons.
Methods: Using California CABG Outcomes Reporting Program data, we classified all isolated
CABG cases in 2003–2004 as having "probable survival enhancing indications (SEIs)", "possible SEIs"
or "non-SEIs." Patient and hospital characteristics associated with SEIs were examined.
Results: While 82.9% of CABG were performed for probable SEIs, the range extended from 68%
to 96% among hospitals and 51% to 100% among surgeons. SEI rates were higher among patients
aged ≥ 65 compared with those aged 18–64 (Adjusted Odds Ratio [AOR] > 1.29 for age groups
65–69, 70–74 and ≥ 75; all p < 0.001), among Asians and Native Americans compared with
Caucasians (AOR 1.22 and 1.15, p < 0.001); and among patients with hypertension, peripheral
vascular disease, diabetes, cerebrovascular disease and congestive heart failure compared to
patients without these conditions (AOR > 1.09, all p < 0.001). Variations in indications for surgery
were more strongly related to patient mix than to surgeon or hospital effects (intraclass correlation
[ICC] = 0.04 for hospital; ICC = 0.01 for surgeon).
Conclusion: California hospitals and surgeons vary in their distribution of indications for CABG
surgery. Further research is required to identify the roles of market factors, referral patterns,
patient preferences, and local clinical culture in producing the observed variations.
Background
Randomized controlled trials and prospective cohort
studies have shown that coronary artery bypass graft
(CABG) surgery is associated with increased survival in
selected patients [1-3]. Nonetheless, the procedure entails
substantial cost [4] and a risk of perioperative mortality
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ranging from 2% to 5% [5-11]. Therefore, careful patient
selection is necessary to ensure that this procedure is per-
formed on patients for whom the benefits (including, but
not limited to mortality reduction) are likely to exceed the
risks. In general, randomized trials favor surgery over
medical therapy or percutaneous coronary intervention
(PCI) for patients with left main or multivessel coronary
artery disease (CAD) with extensive jeopardized myocar-
dium. For other patients, evidence for survival benefit is
less certain, and quality of life considerations dominate
[12-21].
CABG surgery is performed because of anticipated sur-
vival benefit, improvement in quality of life, or both. The
focus of this study is on the subset of CABG surgeries that
are performed because of anticipated survival benefit. At
the level of an individual hospital or surgeon, either a very
low or very high proportion of CABG surgeries performed
for survival enhancing indications (SEIs) could suggest
the need for further inquiry. For example, a low SEI pro-
portion could result from operating on an excess of
patients with equivocal indications for surgery or on too
few patients with SEIs. An extremely high SEI proportion,
in contrast, could mean that the hospital or surgeon is dis-
inclined or unable to offer surgery to patients who might
benefit from CABG surgery in terms of quality of life, or
that an aggressive percutaneous intervention program is
diverting most of these patients.
We performed this study to examine variation in patient
selection for CABG surgery among California hospitals
and surgeons. Specifically, we tested the following
hypotheses: 1) the proportion of CABG performed for sur-
vival-enhancing indications varies across hospitals, across
surgeons, and across metropolitan areas; 2) given known
gender and racial/ethnic disparities in overall rates of
CABG surgery, a higher proportion of CABG is performed
for SEIs (versus more discretionary indications) among
women than among men, among non-Caucasian than
among Caucasian patients, and among patients with
more comorbidities such as hypertension, diabetes and
congestive heart failure; and 3) given that PCI and CABG
are acceptable options for most patients without SEIs, a
higher proportion of CABG is performed for SEIs (versus
more discretionary indications) at hospitals with high PCI
volume (or PCI/CABG volume ratio) than at hospitals
with low PCI volume, and at teaching hospitals than at
non-teaching hospitals.
Methods
Data were obtained from the California CABG Outcomes
Reporting Program (CCORP), managed by California
Office of Statewide Health Planning and Development
[9], which requires California hospitals to submit detailed
clinical information on indications and outcomes for
CABG surgery under the State mandate (SB680, 2001).
During 2003 and 2004, 121 hospitals submitted data
including patient demographics, clinical characteristics,
and observed in-hospital mortality. Hospital data were
linked to the state vital statistics file from California
Department of Health Services (DHS) to identify patients
who died outside the operating hospital within the 30
days following CABG surgery. The data collection system,
based on specifications from the Society of Thoracic Sur-
geons, includes a multi-step cleaning process and annual
onsite audit to ensure data accuracy. Isolated CABG sur-
geries, defined as CABG surgery performed without other
major cardiac procedures such as valve repair or replace-
ment during the same operation, were selected for public
reporting of risk-adjusted operative mortality by hospital
and surgeon. The CCORP data collection procedures and
analysis methodology are described in detail elsewhere
[9].
Classification of Indications for CABG Surgery
The CCORP data collection system includes questions on
the presence or absence of left main CAD, number of dis-
eased coronary vessels, left ventricular ejection fraction
(LVEF) and Canadian Cardiovascular Society classifica-
tion of angina severity. Hospitals are not required to
report whether the proximal left anterior descending
(PLAD) artery was stenotic or bypassed. Accordingly, we
classified all isolated CABG surgeries performed in 2003
and 2004 into one of three indication categories, based on
American College of Cardiology (ACC)/American Heart
Association (AHA) clinical guidelines [12,13]: 1) "proba-
ble survival enhancing indications (SEIs)"; 2) "possible
SEIs" and 3) "non SEIs" (ie., "quality of life indications"
only). Probable SEIs included patients with: 1) left main
CAD (stenosis > 50%) and 2) 3-vessel CAD. Possible SEIs
included patients with 2-vessel CAD with diminished
LVEF (< 50%) or 2-vessel CAD with normal ejection frac-
tion (≥ 50%) but with severe angina (Class 3/4) (assum-
ing PLAD involvement). Non-SEIs included patients with
2-vessel disease with normal LVEF (≥ 50%) and no/mild
angina (Class 0/1/2) (assuming no PLAD involvement) or
with 1-vessel or unknown disease (Table 1).
Statistical Analysis
For descriptive purposes we examined the proportion of
CABG operations performed for probable SEIs, possible
SEIs and non-SEIs by hospital and by surgeon (restricted
to 225 surgeons performing at least 50 procedures per
year, which we chose as an arbitrary threshold reflecting
an "active" surgical practice). To avoid the complexity of
multinomial logistic regression, we dichotomized indica-
tions for each CABG surgery in two alternative ways: 1)
probable SEIs versus possible and non-SEIs (shown in the
tables below), and 2) probable and possible SEIs versus
non-SEIs. The second approach assumes that all patientsBMC Health Services Research 2008, 8:257 http://www.biomedcentral.com/1472-6963/8/257
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with 2-vessel disease and diminished LVEF or severe
angina had PLAD involvement whereas the first approach
assumes that none did. Neither of these assumptions is
completely correct, but they place bounds on the range
containing the true value. Our results from these two
approaches were quite similar (e.g., the Spearman rank
correlation at the hospital level was 0.82, 95% confidence
interval (CI): 75.3%–87.2%), so we present the results of
the first approach only.
We used the standard logistic regression model to exam-
ine whether age, gender, race/ethnicity and preoperative
clinical characteristics were associated with the likelihood
of undergoing CABG surgery for a SEI. Furthermore, we
estimated hierarchical logsitic regression models and used
the results to evaluate the variation attributable to the
patient and to the healthcare provider. The standard logis-
tic regression model is
where Y is a binary outcome variable for patient survival
enhancing indication and follows the Bernoulli distribu-
tion, Y~Bin(1, π); X's are patient-level predictors; μ and β's
are the regression coefficients; i = 1, ..., Ij is the patient level
indicator; j = 1, ..., J is the hospital level indicator; and pij
is the probability of survival enhancing indication for
patient i in hospital j, conditional on the risk factors X's.
The model assumes that patient level random errors eij are
independent with moments E(eij) = 0 and
. The two-level random inter-
cept model is an extension of the standard logistic model
and treats the hospital intercepts as a random variable in
the linear function. In the random hospital intercept
model, the logit is:
where uj are the hospital random effects and it is assumed
that  . It is straightforward to extend the
2-level model to 3-level models that include both hospi-
tal-level and surgeon-level random effects. The models
used in this paper were fitted with SAS GLIMMIX.
Based on previous studies of variation in overall CABG
surgery utilization, we hypothesized that the SEI propor-
tion would be higher among older patients than among
younger patients, higher among women than among
men, higher among minority patients than among Cauca-
sian patients, and higher among patients with more pre-
operative comorbidities. We further hypothesized that
teaching hospitals and other hospitals with active PCI
programs (e.g., hospitals with high PCI volume or a high
ratio of PCI to CABG volume) would have high SEI pro-
portions, because most patients with only quality-of-life
indications would be referred for PCI instead of CABG.
Hospital regions (San Francisco Bay area, Greater Los
Angeles area, Greater San Diego area, and other regions)
were entered into the model as "nuisance" variables to
adjust for regional differences in the relative availability of
cardiologists and thoracic surgeons.
We considered three sources of variation in the hierarchi-
cal logistic model for SEIs in CABG surgery: variation
attributable to the patient, the surgeon and the hospital.
Specifically, we calculated an intraclass correlation (ICC)
coefficient, which describes the fraction of residual vari-
ance (unexplained variation) from the regression on
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Table 1: Survival enhancing indications (SEIs) for coronary artery bypass surgeries in California, 2003–2004
Patient Characteristics N % SEI Status
Left main coronary artery disease (CAD) (Stenosis > 50%) 10,102 25.0 Probable SEIs (N = 33,494, 82.9%)
3-vessel CAD 23,392 57.9
2-vessel CAD with a diminished LVEF (< 50%) 1,458 3.6 Possible SEIs (N = 3,985, 9.9%)
2-vessel CAD with normal LVEF (=> 50%) but Angina class 3/4 2,527 6.3
2-vessel CAD with normal LVEF (=> 50%), Angina class 0/1/2 1,441 3.6 Non-SEIs (N = 2,895, 7.2%)
1-vessel CAD 1,402 3.5
Missing value 52 0.1
Total 40,374 100.0
CAD: coronary artery disease; LVEF: left ventricular ejection fraction;
SEIs: survival enhancing indicationsBMC Health Services Research 2008, 8:257 http://www.biomedcentral.com/1472-6963/8/257
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patient characteristics that is accounted for by differences
among hospitals and/or surgeons [22,23]. For the two-
level logistic model, we estimated the approximate ICC as
follows:
where   is the second level estimated variance and π is
the quantity 3.14159. This method is simple to use but
can produce different estimates of the ICC than other
methods [24,25]. For the logistic models with three levels,
we used an analogous method. Denoting the estimated
variances of hospitals and surgeons as   and  ,
respectively, the ICC values for hospital (h) and surgeon
(s) were calculated as:
The hierarchical model used for computing ICC does not
contain hospital or surgeon level variables. In a separate
model, we calculated hospital random effects to identify
hospitals that were either significantly higher or lower in
SEI proportion when compared to the statewide average,
controlling for patient characteristics. All data analyses
were conducted using SAS version 9.1.3 (Cary, NC). The
authors had full access to the data and take responsibility
for its integrity.
Results
During 2003 and 2004 study period, 302 surgeons per-
formed 40,374 isolated CABG procedures in 121 Califor-
nia hospitals. Overall, 82.9% of CABG operations were
performed for probable SEIs, 9.9% for possible SEIs and
7.2% for non-SEIs. Fifty-two cases could not be classified
due to missing values. Excluding 4,739 CABG patients
with emergent status or prior PCI procedure(s), 83.1% of
CABG operations were performed for probable SEIs, 9.7%
for possible SEIs and 7.2% for non-SEIs. Over two-thirds
of probable SEI cases were comprised of patients with 3-
vessel CAD, while the remainder had left main disease
(Table 1). Non-SEI cases were equally divided between
patients with single vessel disease and patients with two-
vessel disease who had normal left ventricular function
and mild or no angina.
There was substantial variation in the proportion of CABG
surgeries performed for probable SEIs by hospital (mean
83% of CABG operations for a SEI, range 68–96%). The
"probable SEI" rate exceeded 90% in 12 hospitals,
whereas in 12 others the SEI rate was less than 75% (Fig-
ure 1). Variation among surgeons was also substantial
(mean 84%, range 51–100%). Among the 225 surgeons
performing at least 50 CABG surgeries a year, 28 had
"probable SEI" rates exceeding 90% and 21 had rates
below 75% (Figure 2). Using a hierarchical model with
hospital random effects, 18 of 121 hospitals had "proba-
ble SEI" proportions significantly lower than the
statewide average, adjusting for patient demographic and
preoperative clinical characteristics (adjusted odds ratio
[AOR] < 1, p < 0.05), and 17 hospitals had significantly
higher "probable SEI" proportions (AOR > 1, p < 0.05)
(data not shown).
Using hierarchical logistic regression in which patient
demographic and clinical characteristics served as level I
variables and hospital characteristics as level II variables,
the likelihood of undergoing CABG surgery for a probable
SEI was increased among patients in older age groups
compared with patients aged 18–64 (for age 65–69: AOR
= 1.42, 95% CI 1.32–1.52; for 70–74: AOR = 1.29, 95%CI
1.20–1.40; and for age ≥ 75: AOR = 1.29, 95%CI 1.19–
1.39; all p < 0.001) (Additional file 1). Probable SEI was
less likely among women than among men (AOR = 0.67,
95% CI 0.63–0.71, p < 0.001) but more likely among
Asians and Native Americans than among Caucasians
(AOR for Asian = 1.22, 95% CI 1.10–1.35, p < 0.001; AOR
for Native American = 1.15, 95% CI 1.01–1.30, p < 0.05).
Patients with hypertension, peripheral vascular disease
(PVD), diabetes, cerebrovascular disease (CVD) or con-
gestive heart failure (CHF) were more likely to have CABG
for probable SEI (AOR for hypertension = 1.09, 95% CI
1.02–1.16; AOR for pvd = 1.32, 95% CI 1.21–1.44; AOR
for diabetes = 1.25, 95% CI 1.18–1.33; AOR for CVD =
1.23, 95% CI 1.13–1.35; and AOR for CHF = 1.30, 95%
CI 1.20–1.40; all p < 0.01). Controlling for patient demo-
graphic and clinical characteristics, hospital characteristics
(including hospital teaching status, geographic region,
CABG volume, PCI volume, PCI/CABG volume ratio in
2003–2004 and number of performing surgeons and
mean surgeon volume within hospital) were not associ-
ated with the likelihood of having CABG surgery for prob-
able SEIs. The hospital intraclass correlation coefficient,
while significant, was of relatively small magnitude (ICC
= 0.044, 95%CI = 0.030–0.058, p < 0.001), as was the sur-
geon intraclass correlation (ICC = 0.01, 95%CI = 0.003–
0.013, p < 0.001).
To explore differences in patient selection that might
account for the observed between-hospital variation in
SEI rates, we compared aggregated patient characteristics
by hospital group (Additional file 2). Compared with hos-
pitals in the lowest 25th percentile for SEI rate, hospitals
in the upper 25th percentile cared for patients who were
younger and less likely to undergo CABG for emergent
indications but more likely to be non-Caucasian, to have
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had a recent myocardial infarction, to have an ejection
fraction < 40%, and to have left main or 3-vessel CAD
(Table 3).
Discussion
The results of this study show that the vast majority of the
40,374 isolated CABG surgeries performed during 2003
and 2004 in California were associated with "probable" or
"possible" survival enhancing indications. The findings
are consistent with data obtained from more detailed clin-
ical studies of the clinical appropriateness of CABG sur-
gery [13-15], and are, in the aggregate, reassuring.
However, hospitals varied significantly in terms of the
severity of CAD selected for bypass surgery. Most CABG
operations were for SEIs, but in 32 hospitals (26%),
patients lacking a probable SEI constituted at least one-
fifth of patients taken to surgery.
We used a hierarchical logistic regression model on hospi-
tal characteristics and patient demographics to estimate
ICC values, which measures the fraction of variation
(residual variance) that is explained by hospital or sur-
geon or both. We found that these fractions were small for
hospital and surgeon, suggesting that patient mix might
be more important than hospital and surgeon effects in
explaining the variation in use of CABG surgery for SEI.
We also found that the ICC value for hospitals was larger
than the value for surgeons, suggesting that some ele-
ments of cardiac surgical decision making might be
related more directly to hospital referral patterns and cul-
ture than to the judgment of individual surgeons.
For a number of reasons, the proportion of surgeries per-
formed for "probable SEIs" is not a strong measure of
quality or appropriateness at the level of the individual
surgeon or hospital, but this metric may still be useful as
a window into the critical issue of patient selection. As a
ratio measure, the SEI proportion simultaneously reflects
the tendency of providers to perform CABG surgery on
patients with SEIs and to eschew operation on patients
lacking SEIs. Thus, a low SEI rate could indicate failure to
operate on eligible patients with extensive CAD, enthusi-
astic acceptance of patients with minimal disease, or both.
In addition, hospitals and their surgeons may vary in
Distribution of hospitals by CABG surgery for probable survival enhancing indications, California, 2003–2004 Figure 1
Distribution of hospitals by CABG surgery for probable survival enhancing indications, California, 2003–2004. 
SEIs = survival enhancing indications, CABG = Coronary Artery Bypass Graft.
2
10
20
41
36
10
2
0
5
10
15
20
25
30
35
40
45
< 70% 70-74% 75-79% 80-84% 85-89% 90-94% >=95%
Percent of CABG Surgery for SEIs
N
u
m
b
e
r
 
o
f
 
H
o
s
p
i
t
a
l
sBMC Health Services Research 2008, 8:257 http://www.biomedcentral.com/1472-6963/8/257
Page 6 of 8
(page number not for citation purposes)
terms of local referral patterns. An aggressive PCI pro-
gram, for example, could siphon away all but the 3-vessel
and left main disease patients, resulting in a high SEI pro-
portion, whereas in areas with fewer interventional cardi-
ologists, patients may be preferentially shunted towards
surgery, resulting in a low SEI proportion. Our prior
beliefs as to the direction of this effect were not strong; in
fact, it could be argued that a hospital with an enthusiastic
PCI program would have a low SEI proportion if interven-
tionists were handling patients with 3-vessel and left main
coronary disease in preference to CABG surgery. Despite
these limitations, it is reasonable to hypothesize that hos-
pitals with a high SEI rate have a low incidence of inap-
propriate surgery; no conclusions can be drawn about
hospitals with low SEI rates. In any case, the most impor-
tant application of the SEI metric will be to stimulate indi-
vidual hospitals to examine their own data in support of
internal quality improvement.
During the 1980s and 1990s, RAND developed appropri-
ateness criteria [26] for CABG surgery. In a subsequent
multi-institutional study, 74–95% of CABG surgeries
were deemed necessary or crucial [27-29]. Our results are
consistent with the RAND findings. However, the CCORP
(and STS) data currently lack certain information availa-
ble to RAND investigators, including left anterior
descending (LAD) coronary artery involvement and the
intensity of medical management. As a result of this study,
the Clinical Advisory Panel, the oversight body of the
CCORP, has approved recommendations to add LAD
involvement as a required new element for statewide data
collection.
In the multivariable analysis, patients in older age groups
(over age 65) undergoing CABG surgery were more likely
than younger patients to have a "probable SEI." Similarly,
CABG patients with significant chronic comorbidities
such as hypertension, PVD, diabetes, CVD and CHF were
Distribution of Surgeons by CABG surgery for probable survival enhancing indications, California, 2003–2004 Figure 2
Distribution of surgeons by CABG surgery for probable survival enhancing indications, California, 2003–2004. 
(Note: Limited to 225 surgeons performing at least 50 CABG surgeries a year). SEIs = survival enhancing indications, CABG = 
Coronary Artery Bypass Graft.
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more likely than CABG patients without those comorbid-
ities to have a "probably SEI." The most plausible expla-
nation for this finding is that surgeons may "screen out"
elderly and chronically ill patients without SEIs [due to
concern about their perioperative risk in the setting of
uncertain survival benefit) and refer them back to cardiol-
ogists for possible PCI or medical therapy. Of course, pri-
mary care physicians and cardiologists may also be less
likely to refer elderly and chronically ill patients without
SEIs to surgeons, for the same reason. The higher "proba-
ble SEI" rate among men than women was unexpected,
but may reflect unmeasured gender differences in the
spectrum of coronary disease (e.g., prevalence of LAD
involvement with one or two-vessel disease).
In summary, the "probable SEI" proportion varies sub-
stantially among California hospitals that perform CABG
surgery. Extreme values of this metric do not necessarily
indicate a problem with quality. In particular, we need to
know whether low SEI rates at the hospital level correlate
with clinical inappropriateness, using more detailed
methods such as the RAND approach. Additional research
is also needed to determine whether the observed varia-
tion in patient selection results from market factors, refer-
ral patterns, patient preferences, or local clinical culture.
Also, hospitals with SEI proportions at the extreme high-
or low-end of the distribution may wish to examine their
own data in more detail to assure themselves that patient
selection is occuring in accord with current standards of
evidence and practice.
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